Table 5.
Antimicrobial susceptibility profiles of Campylobacter species isolated from various sources.
| Antimicrobial classes | Antimicrobial | Number (%) of resistant Campylobacter from different sources | ||||||
|---|---|---|---|---|---|---|---|---|
| Human (n = 10) | Cattle (n = 25) | Sheep (n = 4) | Goat (n = 1) | Poultry (n = 9) | Water (n = 18) | Total (n = 67) | ||
| Aminoglycosides | Amikacin | 9 (90.0) | 18 (72.0) | 4 (100.0) | 1 (100.0) | 7 (77.8) | 14 (77.8) | 53 (79.1) |
| Gentamycin | 3 (30.0) | 9 (36.0) | 2 (50.0) | 0 (0.0) | 2 (33.3) | 4 (22.2) | 21 (31.3) | |
| Macrolides | Azithromycin | 7 (70.0) | 14 (56.0) | 2 (50.0) | 1 (100.0) | 5 (55.6) | 11 (61.1) | 40 (59.7) |
| Erythromycin | 8 (80.0) | 14 (56.0) | 1 (25.0) | 1 (100.0) | 6 (66.7) | 11 (61.1) | 41 (61.2) | |
| Penicillin | Amoxicillin-clavulanic acid | 7 (70.0) | 15 (60.0) | 2 (50.0) | 0 (0.0) | 8 (88.9) | 15 (83.3) | 47 (70.1) |
| Ampicillin | 6 (60.0) | 15 (60.0) | 2 (50.0) | 0 (0.0) | 6 (66.7) | 14 (77.8) | 43 (64.2) | |
| Phenicol | Chloramphenicol | 2 (20.0) | 5 (20.0) | 2 (50.0) | 1 (100.0) | 0 (0.0) | 3 (16.7) | 13 (19.4) |
| Potentiated sulfonamides | Sulfamethoxazole/trimethoprim | 2 (20.0) | 13 (52.0) | 3 (75.0) | 1 (100.0) | 2 (33.3) | 6 (33.3) | 28 (41.8) |
| Quinolones | Ciprofloxacin | 5 (50.0) | 14 (56.0) | 4 (100.0) | 1 (100.0) | 7 (77.8) | 11 (61.1) | 42 (62.7) |
| Nalidixic acid | 6 (60.0) | 13 (52.0) | 1 (25.0) | 1 (100.0) | 6 (66.7) | 16 (88.9) | 43 (64.2) | |
| Tetracycline | Tetracycline | 7 (70.0) | 17 (68.0) | 4 (100.0) | 1 (100.0) | 5 (55.6) | 11 (61.1) | 45 (67.2) |